Kymera Therapeutics, Inc.KYMRNASDAQ
Loading
Gross Margin Over TimeStable
Percentile Rank29
3Y CAGR0.0%
5Y CAGR0.0%
Studio
Year-over-Year Change

Gross profit as a percentage of revenue

3Y CAGR
0.0%/yr
Annual compound
5Y CAGR
0.0%/yr
Consistent
Percentile
P29
Within normal range
vs 5Y Ago
1x
Modest growth
PeriodValueYoY Change
TTM100.00%0.0%
2024100.00%0.0%
2023100.00%0.0%
2022100.00%0.0%
2021100.00%0.0%
2020100.00%+39.1%
201971.88%-
20180.00%-